Postdoctoral Fellow
University of Delaware
Michael Donzanti is a Postdoctoral Fellow at the University of Delaware Institute of Engineering Driven Health in Newark, DE. He earned a PhD in Biomedical Engineering at the University of Delaware, and his interests are at the intersection of lymph node physiology, drug delivery, and immunology. He also serves as CEO and Co-Founder of Navicyte Biotechnologies, a biotech startup pioneering a first-in-class lymphocyte-mimetic drug delivery platform to overcome one of the greatest limitations in oncology: the inability to safely and effectively deliver therapeutics to immune-rich sites like the lymph node.
